🇺🇸 FDA
Patent

US 8410288

Polymorphs of Saxagliptin hydrochloride and processes for preparing them

granted A61KA61K31/403A61P

Quick answer

US patent 8410288 (Polymorphs of Saxagliptin hydrochloride and processes for preparing them) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/403, A61P, A61P3/00, A61P3/08